attachment
attachment

diagnosis

Reading File
Finding Sources
Finding Sources
Reading File
Searching Images

tinea corporis annular erythematous plaque back ringworm

Based on analysis of both images and the textbook findings, here is the clinical assessment:

Diagnosis: Tinea Corporis (Dermatophytosis / "Ringworm")

Clinical Features Supporting This Diagnosis

Image 1 (mid-back):
  • Large, well-demarcated annular plaque with erythematous, slightly raised, scaly border
  • Central clearing — characteristic centrifugal spread
  • Fine peripheral scaling at the active edge
  • Location on trunk (common site)
Image 2 (axilla/shoulder):
  • Curved erythematous arc with a scaling, advancing border
  • Violaceous-brown hue consistent with darker skin phototype
  • Perimeter involvement near axilla — a warm, moist site favoring dermatophytes

Pathophysiology

Tinea corporis is caused by dermatophyte fungi (Trichophyton, Microsporum, Epidermophyton species) infecting the stratum corneum. The lesion starts as a papule and expands centrifugally, producing the classic ring morphology with a trailing or leading scale at the advancing border. — Fitzpatrick's Dermatology, Vol. 1

Key Differential Diagnoses to Exclude

ConditionDistinguishing Feature
Erythema annulare centrifugum (EAC)"Trailing scale" on inner edge; often no pruritis; associated with systemic triggers
Granuloma annulareFlesh-colored, non-scaly; no epidermal change
Nummular eczemaCoin-shaped, intensely pruritic, oozing/crusting
Pityriasis roseaHerald patch; collarette scale; follows Langer's lines
Psoriasis (annular)Thick silvery scale; other psoriatic features

Recommended Workup

  • KOH preparation of scale scraping from the advancing border — most rapid confirmatory test
  • Fungal culture if KOH equivocal
  • Wood's lamp (limited utility for Trichophyton species)

Management

  • Topical antifungals (first-line for localized disease): Terbinafine 1% cream once daily × 2 weeks, or Clotrimazole/Miconazole twice daily × 4 weeks
  • Oral therapy (large/extensive/recalcitrant lesions): Terbinafine 250 mg/day × 2–4 weeks or Griseofulvin
  • Treat any concurrent tinea pedis/unguium to prevent recurrence
  • Avoid sharing towels, clothing; keep skin dry
Note: Given the involvement of multiple body sites (back and axilla), oral antifungal therapy may be preferred over topical alone. A formal clinical examination and KOH confirmation is recommended before initiating treatment.
This is a shared conversation. Sign in to Orris to start your own chat.